2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American heart Association Task Force on Practice Guidelines Public Deposited

Downloadable Content

Download PDF
  • Smith, Sidney C., Jr.
    • Affiliation: School of Medicine, Division of Cardiology, Department of Medicine
  • Stone, Neil J.
  • D’Agostino, Ralph B., Sr.
  • Schwartz, J. Sanford
  • Goff, David C., Jr.
  • Greenland, Philip
  • Gibbons, Raymond
  • Bennett, Glen
  • O’Donnell, Christopher J.
  • Coady, Sean
  • Shero, Susan T.
  • Sorlie, Paul
  • Lloyd-Jones, Donald M.
  • Lackland, Daniel T.
  • Wilson, Peter W. F.
  • Robinson, Jennifer G.
  • Levy, Daniel
  • 1.1. Organization of the Work Group: The Risk Assessment Work Group (Work Group) was composed of 11 members and 5 ex-officio members, including internists, cardiologists, endocrinologists, and experts in cardiovascular epidemiology, biostatistics, healthcare management and economics, and guideline development. 1.2. Document Review and Approval: A formal peer review process, which included 12 expert reviewers and representatives of federal agencies, was initially completed under the auspices of the NHLBI. This document was also reviewed by 3 expert reviewers nominated by the ACC and the AHA when the management of the guideline transitioned to the ACC/AHA. The ACC and AHA Reviewers’ RWI information is published in this document (Appendix 2). This document was approved for publication by the governing bodies of the ACC and AHA and endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, American Society for Preventive Cardiology, American Society of Hypertension, Association of Black Cardiologists, National Lipid Association, Preventive Cardiovascular Nurses Association, and WomenHeart: The National Coalition for Women With Heart Disease. 1.3. Charge to the Work Group: The Work Group was 1 of 3 work groups appointed by the NHLBI to develop its own recommendations and provide cross-cutting input to 3 Panels for updating guidelines on blood cholesterol, blood pressure (BP), and overweight/obesity. The Work Group was asked to examine the scientific evidence on risk assessment for initial ASCVD events and to develop an approach for quantitative risk assessment that could be used in practice and used or adapted by the risk factor panels (blood cholesterol, hypertension, and obesity) in their guidelines and algorithms. Specifically, the Work Group was charged with 2 tasks: 1) To develop or recommend an approach to quantitative risk assessment that could be used to guide care; and 2) To use systematic review methodology to pose and address a small number of questions judged to be critical to refining and adopting risk assessment in clinical practice.
Date of publication
  • doi:10.1161/01.cir.0000437741.48606.98
  • 2-s2.0-84903159932
Related resource URL
Resource type
  • Journal Item
Rights statement
  • In Copyright
Journal title
  • Circulation
Journal volume
  • 129
Journal issue
  • 25 SUPPL. 1
Page start
  • S49
Page end
  • S73
  • English
  • Postprint
  • ‎0009-7322

This work has no parents.